BIO-TECHNE CORP (TECH) Fundamental Analysis & Valuation
NASDAQ:TECH • US09073M1045
Current stock price
53.13 USD
-0.35 (-0.65%)
At close:
53.13 USD
0 (0%)
After Hours:
This TECH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. TECH Profitability Analysis
1.1 Basic Checks
- TECH had positive earnings in the past year.
- TECH had a positive operating cash flow in the past year.
- TECH had positive earnings in each of the past 5 years.
- In the past 5 years TECH always reported a positive cash flow from operatings.
1.2 Ratios
- TECH has a better Return On Assets (3.17%) than 75.00% of its industry peers.
- With a decent Return On Equity value of 3.98%, TECH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 9.52%, TECH belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
- TECH had an Average Return On Invested Capital over the past 3 years of 9.00%. This is below the industry average of 11.38%.
- The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROIC | 9.52% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
- With a decent Profit Margin value of 6.58%, TECH is doing good in the industry, outperforming 69.64% of the companies in the same industry.
- TECH's Profit Margin has declined in the last couple of years.
- TECH's Operating Margin of 22.59% is amongst the best of the industry. TECH outperforms 92.86% of its industry peers.
- TECH's Operating Margin has been stable in the last couple of years.
- TECH's Gross Margin of 66.60% is amongst the best of the industry. TECH outperforms 87.50% of its industry peers.
- In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. TECH Health Analysis
2.1 Basic Checks
- TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- TECH has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for TECH has been increased compared to 5 years ago.
- TECH has a worse debt/assets ratio than last year.
2.2 Solvency
- TECH has an Altman-Z score of 11.44. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
- TECH has a better Altman-Z score (11.44) than 96.43% of its industry peers.
- The Debt to FCF ratio of TECH is 1.17, which is an excellent value as it means it would take TECH, only 1.17 years of fcf income to pay off all of its debts.
- TECH's Debt to FCF ratio of 1.17 is amongst the best of the industry. TECH outperforms 91.07% of its industry peers.
- TECH has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.13, TECH is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Altman-Z | 11.44 |
ROIC/WACC0.87
WACC10.94%
2.3 Liquidity
- TECH has a Current Ratio of 4.54. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 4.54, TECH is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
- TECH has a Quick Ratio of 3.08. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
- TECH's Quick ratio of 3.08 is fine compared to the rest of the industry. TECH outperforms 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 |
3. TECH Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 8.84% over the past year.
- The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
- TECH shows a small growth in Revenue. In the last year, the Revenue has grown by 1.64%.
- Measured over the past years, TECH shows a quite strong growth in Revenue. The Revenue has been growing by 10.55% on average per year.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
3.2 Future
- TECH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.61% yearly.
- Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y5.04%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
EPS Next 5Y8.61%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.57%
Revenue Next 5Y7.1%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. TECH Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 26.97, TECH can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, TECH is valued a bit cheaper than 71.43% of the companies in the same industry.
- TECH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.17.
- Based on the Price/Forward Earnings ratio of 23.88, the valuation of TECH can be described as rather expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 71.43% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 23.05. TECH is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.97 | ||
| Fwd PE | 23.88 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, TECH is valued a bit cheaper than 66.07% of the companies in the same industry.
- 64.29% of the companies in the same industry are more expensive than TECH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.27 | ||
| EV/EBITDA | 22.2 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
- TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.35
PEG (5Y)2.4
EPS Next 2Y7.37%
EPS Next 3Y10.09%
5. TECH Dividend Analysis
5.1 Amount
- TECH has a yearly dividend return of 0.63%, which is pretty low.
- TECH's Dividend Yield is rather good when compared to the industry average which is at 0.12. TECH pays more dividend than 92.86% of the companies in the same industry.
- With a Dividend Yield of 0.63, TECH pays less dividend than the S&P500 average, which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.63% |
5.2 History
- The dividend of TECH has a limited annual growth rate of 0.11%.
- TECH has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of TECH decreased in the last 3 years.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
- TECH pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.38%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
TECH Fundamentals: All Metrics, Ratios and Statistics
53.13
-0.35 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/bmo
Inst Owners113.95%
Inst Owner Change0.01%
Ins Owners0.25%
Ins Owner Change1.57%
Market Cap8.31B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts80.87
Price Target76.73 (44.42%)
Short Float %7.92%
Short Ratio5.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.63% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-13 2026-02-13 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)0%
PT rev (3m)7.67%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)-4.54%
EPS NY rev (1m)0%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.97 | ||
| Fwd PE | 23.88 | ||
| P/S | 6.84 | ||
| P/FCF | 37.27 | ||
| P/OCF | 33.34 | ||
| P/B | 4.13 | ||
| P/tB | 11.95 | ||
| EV/EBITDA | 22.2 |
EPS(TTM)1.97
EY3.71%
EPS(NY)2.23
Fwd EY4.19%
FCF(TTM)1.43
FCFY2.68%
OCF(TTM)1.59
OCFY3%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)5.35
PEG (5Y)2.4
Graham Number23.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROCE | 11.53% | ||
| ROIC | 9.52% | ||
| ROICexc | 10.26% | ||
| ROICexgc | 25.36% | ||
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% | ||
| FCFM | 18.35% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Debt/EBITDA | 0.69 | ||
| Cap/Depr | 25.35% | ||
| Cap/Sales | 2.16% | ||
| Interest Coverage | 15.32 | ||
| Cash Conversion | 65.89% | ||
| Profit Quality | 278.92% | ||
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 | ||
| Altman-Z | 11.44 |
F-Score8
WACC10.94%
ROIC/WACC0.87
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y5.04%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.57%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year16.56%
EBIT Next 3Y11.92%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status of BIO-TECHNE CORP (TECH) stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
Can you provide the profitability details for BIO-TECHNE CORP?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
Can you provide the financial health for TECH stock?
The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.
What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?
The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 5.04% in the next year.